PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biology of Vector-Borne Viruses Section, Laboratory of Virology, Rocky Mountain Laboratories, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.\', \'Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.\', \'Innate Immunity and Pathogenesis Section Laboratory of Virology, Rocky Mountain Laboratories, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.\', \'Coxiella Pathogenesis Section, Laboratory of Bacteriology, Rocky Mountain Laboratories, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • E810.3390/v13010008
?:hasPublicationType
?:journal
  • Viruses
is ?:pmid of
?:pmid
?:pmid
  • 33374514
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.805
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all